SOUTH SAN FRANCISCO, Calif.,
April 19, 2017 /PRNewswire/ --
Veracyte, Inc. (NASDAQ: VCYT) today announced that it will report
its first quarter 2017 financial results after close of market
on Wednesday, May 3, 2017. Following the
announcement, Veracyte's management will host a live
conference call and webcast at 4:30 p.m. Eastern Time to
discuss the company's financial results and business progress.
The live webcast and subsequent replay may be accessed by
visiting Veracyte's website
at http://investor.veracyte.com. Alternatively, please call
(855) 541-0980 (U.S.) or (970) 315-0440 (international) to listen
to the live conference call. The conference ID number is 4181279.
The webcast replay will be available on the company's website
approximately two hours following completion of the call and
archived on the company's website for 90 days.
About Veracyte
Veracyte (NASDAQ: VCYT) is a leading genomic diagnostics
company that is fundamentally improving patient care by resolving
diagnostic uncertainty with evidence that is trustworthy and
actionable. The company's products uniquely combine genomic
technology, clinical science and machine learning to provide
answers that give physicians and patients a clear path forward
without risky, costly surgery that is often unnecessary. Since its
founding in 2008, Veracyte has commercialized three
genomic tests, which are transforming the diagnosis of thyroid
cancer, lung cancer and idiopathic pulmonary fibrosis and
collectively target a $2 billion market
opportunity. Veracyte is based in South San Francisco, California. For more
information, please visit www.veracyte.com and follow the
company on Twitter (@veracyte).
Veracyte and the Veracyte logo are trademarks
of Veracyte, Inc.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/veracyte-to-host-conference-call-and-webcast-to-discuss-first-quarter-2017-financial-results-on-wednesday-may-3-2017-300441908.html
SOURCE Veracyte